$6.19 Million is the total value of Copernicus Capital Management, LLC's 14 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
REGN | New | REGENERON PHARMACEUTICALS | $710,000 | – | 1,500 | +100.0% | 11.47% | – |
RVMD | New | REVOLUTION MEDICINES INC | $459,000 | – | 10,000 | +100.0% | 7.42% | – |
GRTS | New | GRITSTONE ONCOLOGY INC | $349,000 | – | 37,000 | +100.0% | 5.64% | – |
ARDX | New | ARDELYX INC | $331,000 | – | 50,000 | +100.0% | 5.35% | – |
RCUS | New | ARCUS BIOSCIENCES INC | $281,000 | – | 10,000 | +100.0% | 4.54% | – |
BCEL | New | ATRECA INC | $276,000 | – | 18,000 | +100.0% | 4.46% | – |
ORTX | New | ORCHARD THERAPEUTICS PLCads | $109,000 | – | 15,000 | +100.0% | 1.76% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VERTEX PHARMACEUTICALS INC | 15 | Q2 2021 | 28.6% |
THERMO FISHER SCIENTIFIC INC | 10 | Q3 2021 | 13.8% |
ZOETIS INC | 10 | Q1 2020 | 13.0% |
FATE THERAPEUTICS INC | 9 | Q3 2021 | 13.7% |
ILLUMINA INC | 9 | Q4 2019 | 11.8% |
BIOMARIN PHARMACEUTICAL INC | 8 | Q3 2021 | 14.7% |
BRISTOL-MYERS SQUIBB CO | 8 | Q4 2020 | 12.2% |
INTUITIVE SURGICAL INC | 7 | Q2 2019 | 11.8% |
STRYKER CORP | 7 | Q2 2019 | 11.6% |
IQVIA HLDGS INC | 7 | Q4 2020 | 8.2% |
View Copernicus Capital Management, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2021-11-15 |
13F-HR | 2021-08-16 |
13F-HR | 2021-05-17 |
13F-HR | 2021-02-16 |
13F-HR | 2020-11-16 |
13F-HR | 2020-08-14 |
13F-HR | 2020-05-14 |
13F-HR | 2020-02-14 |
13F-HR | 2019-11-14 |
13F-HR | 2019-08-14 |
View Copernicus Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.